Middle East Conflict Weighs On Core Laboratories' Q1 Outlook

CLB cut its Q1 2026 guidance after operations were disrupted by geopolitical tensions, citing supply-chain disruptions and weaker client activity. The guidance reduction signals near-term revenue and client-pipeline weakness and is likely to put downward pressure on the stock and sector sentiment.

Analysis

CLB cut its Q1 2026 guidance after operations were disrupted by geopolitical tensions, citing supply-chain disruptions and weaker client activity. The guidance reduction signals near-term revenue and client-pipeline weakness and is likely to put downward pressure on the stock and sector sentiment.